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Abstract
The stroke-prone spontaneously hypertensive rat (SHRSP) is known to have exaggerated sympathetic nerve activity to
various types of stress, which might contribute to the pathogenesis of severe hypertension and stroke observed in this
strain. Previously, by using a congenic strain (called SPwch1.72) constructed between SHRSP and the normotensive Wistar-
Kyoto rat (WKY), we showed that a 1.8-Mbp fragment on chromosome 1 (Chr1) of SHRSP harbored the responsible gene(s)
for the exaggerated sympathetic response to stress. To further narrow down the candidate region, in this study, another
congenic strain (SPwch1.71) harboring a smaller fragment on Chr1 including two functional candidate genes, Phox2a and
Ship2, was generated. Sympathetic response to cold and restraint stress was compared among SHRSP, SPwch1.71,
SPwch1.72 and WKY by three different methods (urinary norepinephrine excretion, blood pressure measurement by the
telemetry system and the power spectral analysis on heart rate variability). The results indicated that the response in
SPwch1.71 did not significantly differ from that in SHRSP, excluding Phox2a and Ship2 from the candidate genes. As the
stress response in SPwch1.72 was significantly less than that in SHRSP, it was concluded that the 1.2-Mbp congenic region
covered by SPwch1.72 (and not by SPwch1.71) was responsible for the sympathetic stress response. The sequence analysis
of 12 potential candidate genes in this region in WKY/Izm and SHRSP/Izm identified a nonsense mutation in the stromal
interaction molecule 1 (Stim1) gene of SHRSP/Izm which was shared among 4 substrains of SHRSP. A western blot analysis
confirmed a truncated form of STIM1 in SHRSP/Izm. In addition, the analysis revealed that the protein level of STIM1 in the
brainstem of SHRSP/Izm was significantly lower when compared with WKY/Izm. Our results suggested that Stim1 is a strong
candidate gene responsible for the exaggerated sympathetic response to stress in SHRSP.
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Introduction
The sympathetic nervous system (SNS) has been implied to play
a key role in the pathogenesis of hypertension [1]. In the classical
physiology, SNS is thought particularly important in modulating
cardiovascular functions to cope with the various stresses and
environmental changes [2]. The stroke-prone spontaneously
hypertensive rats (SHRSP) are known to be vulnerable to various
types of stress, which might contribute to the pathogenesis of
severe hypertension and stroke observed in this strain [3–5], and
thus the genetic factors underlying this may provide us important
clues to understand some aspects of the pathogenesis of
hypertension in humans. To identify the genomic region
controlling the exaggerated sympathetic response to stress in
SHRSP, we constructed reciprocal congenic strains between
SHRSP and the normotensive Wistar-Kyoto rat (WKY) and
compared physiological stress responses among congenic strains.
In the previous study, we found that SPwch1.72, a congenic strain
carrying a 1.8-Mbp of WKY fragment of chromosome 1 (Chr1) on
the SHRSP background, had significantly lower sympathetic
response to stress than did SHRSP [5]. This finding indicated that
a gene (or genes) responsible for exaggerated sympathetic response
to stress in SHRSP was located in the 1.8-Mbp region on Chr1. In
this region, several interesting candidate genes were found such as
the paired mesoderm homeobox protein 2a (Phox2a) and the SH2
domain-containing inositol 59-phosphatase (Ship2).
PHOX2A is a transcription factor regulating the expression of
the tyrosine hydroxylase (Th) in noradrenergic neurons [6,7].
PHOX2A may thus play a key role in the pathogenesis of
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hypertension through controlling the activity of SNS. SHIP2 is
a phosphatase encoded by Inppl1, and was described to negatively
control the activity of the phosphatidylinositol 3-kinase (PI3K) [8].
Marion et al. identified a missense variation, R1142C, in the
Ship2 gene of the Goto-Kakizaki (GK) diabetic rat and SHR,
which reduced the signals downstream of PI3K probably due to
the increased SHIP2 activity [9]. We confirmed that SHRSP
shared the same variation with GK rats and SHR (data not
shown), and as the pathway including PI3K was involved in the
signal transduction activated by several vasoactive substances
[10,11], functional changes in SHIP2 may be causally related to
hypertension in SHR and SHRSP.
Based on such observation, we attempted to construct another
congenic strain harboring a smaller fragment including these
candidate genes. In this report, physiological evaluation of the
stress responses in a new congenic strain (SPwch1.71) indicated
that the region harboring Phox2a and Ship2 was not likely to have
causative roles in the exaggerated stress response in SHRSP. In
spite of that, further attempt to explore causative genes in the
remaining candidate region succeeded to identify another strong
candidate gene, the stromal interaction molecule 1 (Stim1).
Materials and Methods
Ethics Statement
All experimental protocols of animal studies were approved by
the ethics committee for animal research of Shimane University
(#IZ23-60 and #IZ23-63).
Animal Studies
SHRSP/Izm and WKY/Izm were provided by the Disease
Model Cooperative Research Association (Kyoto, Japan). A
congenic strain harboring a WKY-derived small fragment in-
cluding Phox2a and Ship2 was newly constructed as described
previously [5]. Briefly, a congenic strain, harboring the WKY-
fragment between D1Smu13 and D1Wox33 [SHRSP.WKY-
(D1Smu13-D1Wox33)/Izm (abbreviated as SPwch1.72, see
Figure 1)] was backcrossed with SHRSP/Izm, and the resulted
F1 rats were intercrossed with one another to obtain F2 rats.
Approximately a hundred F2 rats were genotyped to identify a pup
with a recombination between D1Smu13 and D1Rat51 (Figure 1).
The F2 rat with the recombination was then backcrossed with
SHRSP/Izm to obtain male and female heterozygotes, which
were mated with each other to establish a new congenic strain with
a homozygous WKY fragment only at the D1Smu13 locus
[SHRSP.WKY-(D1Smu13)/Izm (abbreviated as SPwch1.71)]
(Figure 1). Recombinant breakpoints in each congenic strain were
determined by SNP-based genotyping as described below. Male
rats of 12 weeks of age were used in all experiments.
Physiological Evaluation of Stress Responses in Congenic
Strains
The responsiveness to restraint and cold stress was examined as
described in the previous study [5]; briefly, restraint stress was
imposed by placing rats for 3 h in a stainless-steel holder adjusted
to the rat’s body size. As for cold stress, a rat was placed in a cage
kept at 4uC for 3 h (in the telemetry experiments) or for 6 h (in the
collection of urine samples). All experiments for the evaluation of
stress response were performed in the afternoon with the light on.
Urinary NE was measured in urine samples by HPLC. The
power spectral analysis was done on heart rate variability under
restraint stress using the telemetry for ECG (Data Science Inc, St.
Paul, MN). The analysis was performed on the ECG using the
software implemented in the telemetry system. The ratio between
the low frequency (LF; 0.04–1.0 Hz) and the high frequency
component (HF; 1.0–3.0 Hz) was used as an indicator of the
relative sympathetic activity [5]. The LF/HF ratio was recorded
for 30 s in every 10 min throughout the experiment, and the
change in LF/HF (DLF/HF) was calculated as the difference
between the averaged LF/HF during the periods with and without
the stresses. Blood pressure (BP) and heart rate (HR) changes
under restraint and cold stress were monitored with the telemetry
system for BP (Data Science Inc, St. Paul, MN). BP and HR were
monitored for 10 s in every 10 min during the experiment. The
change in BP (DBP) and in HR (DHR) was calculated as the
difference between the averaged BPs during the periods with and
without the stresses.
Whole Genome Sequencing
Sequencing was performed on AB SOLiD 4 System (Life
Technologies, Carlsbad, CA) as previously described [12].
Sequenced libraries were prepared from the whole genome
DNA of SHRSP/Izm, SHR/Izm and WKY/Izm according to
manufactures instructions using the AB EZ Bead System (Life
Technologies, Carlsbad, CA). The size of inserts in fragment and
paired-end runs ranged between 210 bp and 300 bp and between
145 bp and 230 bp, respectively. The read length in fragment and
paired-end runs was 50 bp and 85 bp, respectively. Five hundred
million reads were obtained for the genome of each strain, which
covered approximately 20 times the rat genome. The sequence
reads were mapped on the Rattus norvegicus genome assembly
(rn4) with bowtie (version 0.12.8) [13]. Sequence variations
between SHRSP and WKY in the target chromosomal fragments
were explored using SAMtools [14].
mRNA and Protein Expression Analyses
12-weeks old male SHRSP/Izm and WKY/Izm were employed
in the experiments. Rats were divided into two groups (N=5 in
each group); one group was kept at a room temperature while the
other was exposed to cold stress at 4uC for 6 hours. The rats were
then sacrificed under deep anesthesia (by inhalation of diethyl
ether) and the brain was dissected quickly. The ventrolateral
portion of the brainstem including the rostral ventrolateral
medulla (RVLM) was further dissected on ice for RNA and
protein extraction.
Total RNA was isolated from the dissected ventrolateral portion
of the brainstem using Sepasol-RNA I Super G (Nakalai Tesque,
Kyoto, Japan) according to the manufacturer’s instruction.
Complementary DNA was synthesized using PrimeScript RT
reagent Kit with gDNA Eraser (Takara Bio, Shiga, Japan) with
oligo dT primer and random 6mers. Quantitative reverse
transcription PCR (RT-PCR) was performed using the Real-time
PCR system 7300 (Applied Biosystems, Foster City, CA) in a total
volume of 25 ml of reaction mixture using SYBR Premix EX-
TaqII (Takara Bio, Shiga, Japan). Quantity of mRNA was
standardized on the b-actin mRNA. Primers used in the
experiment were listed in Table S1.
Protein samples of the ventrolateral portion of the brainstem
were prepared using RIPA buffer (Nakalai Tesque, Kyoto, Japan)
containing 50 mmol/L Tris-HCl (pH7.6), 150 mmol/L NaCl,
1.0% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% sodium
dodecyl sulfate with a protease inhibitor cocktail, following
manufacturer’s instruction. The protein concentration was de-
termined using Protein Assay Bicinchoninate kit (Nakalai Tesque,
Kyoto, Japan). Protein samples were separated by SDS-PAGE and
transferred to Immobilon-P transfer membrane (Millipore, Bill-
erica, MA). Non-specific binding sites were blocked using PVDF
Blocking Reagent (TOYOBO, Osaka, Japan). Western blotting
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was performed as previously described [15]. ECL Prime Western
Blotting Detection Reagent (GE Healthcare, Buckinghamshire,
UK) was used for chemiluminescence reaction and the fluores-
cence image was captured with ImageQuant LAS-4000 (GE
Healthcare, Buckinghamshire, UK). Antibodies used in this
experiment were as follows: anti-STIM1 (N-terminal) antibody
(S6072, 1:500, Sigma-Aldrich, St. Louis, MO), anti-b-actin (clone
AC-15, 1:2000, Sigma-Aldrich, St. Louis, MO), peroxidase-
conjugated goat anti-rabbit IgG polyclonal antibody (1:2000,
Dako, Glostrup, Denmark), and peroxidase-conjugated sheep anti-
mouse IgG polyclonal antibody (GE Healthcare, Buckingham-
shire, UK). All antibodies used in this experiment were diluted in
Can Get Signal solution (TOYOBO, Osaka, Japan).
Single Nucleotide Polymorphism (SNP)-based
Genotyping
DNA samples of W/KYO, WKYO/Kyo, WKY/Crj, SDJ/
Hok, LEJ/Hok, SS/JrNgs and SR/JrNgs were provided through
the National Bio-Resource Project for Rats [16]. Genomic DNA
of other rat strains listed below were extracted from frozen liver
tissues or blood using Gentra puregene kit (Qiagen, Hilden,
Germany) or DnaQuick II (DS Pharma Biomedical, Osaka, Japan)
according to the manufacturer’s instruction. Examined strains
were as follows; SPwch1.71 and SPwch1.72 (constructed as
described above), LEW/SsNslc and F344/SsNslc (purchased from
SLC, Hamamatsu, Japan), SHRSP/Izm, WKY/Izm, SHRB2,
SHRCH, SHRCL, SHRSPA1-sb and SHRSPA4 (provided by the
Disease Model Cooperative Research Association, Kyoto, Japan),
SHR/Kyushu (provided by Dr. Setsuro Ibayashi), SHRSP/Ngsk
(provided by Dr. Masami Niwa) and SHRSP/Ezo (provided by
Dr. Hiroko Togashi). SNP typing was performed by direct
sequencing of PCR products amplified with primers listed in
Table S2 using BigDye terminator v.1.1 (Applied Biosystems,
Foster City, CA) and the 3130 Genetic Analyzer (Applied
Biosystems, Foster City, CA).
Statistics
Means and standard deviations are shown in the figures, tables
and the text. Inter-strain differences were tested either by
Student’s t-test or by ANOVA with Dunnett’s post-hoc test. P,
0.05 was considered to be statistically significant.
Results
Physiological Evaluation of the Congenic Strains
Effects of cold and restraint stress on BP, HR, DLF/HF and
urinary NE excretion were summarized in Table 1.
BP of SPwch1.71 did not differ significantly from that of
SHRSP when measured by the telemetry method (Table 1). When
BP change under the cold and restraint stress was monitored by
the telemetry, the response in SPwch1.71 was not significantly
different from that in SHRSP, while SPwch1.72 showed blunted
response that was comparable with that in WKY (Table 1). In
accordance with this observation, increase in urinary NE excretion
under the cold stress did not differ significantly between
SPwch1.71 and SHRSP, while the response in SPwch1.72 was
significantly less than that in SHRSP (Table 1). Further, a power
spectral analysis on HR variation indicated that DLF/HF,
a parameter of the relative sympathetic activity [5], under the
restraint stress was comparable between SHRSP and SPwch1.71,
whereas a significant reduction was observed in SPwch1.72
(Table 1).
Collectively, the results of these physiological experiments
indicated that the region covered by SPwch1.71 did not contribute
to the difference in the sympathetic stress response between
SHRSP and WKY, and could be excluded from the candidate
region.
Figure 1. Genetic map of the congenic region and candidate genes located in the region. Closed columns indicate the regions transferred
from the WKY genome. Vertical lines on the both ends of the columns show intervals including recombination breakpoints. Supplementary Table S3
is available for further information about the candidate genes. Genomic position of each simple sequence repeat marker and SNPs in the Trpc2, Art5
and Olr111 are defined based on RGSC Genome Assembly v3.4.
doi:10.1371/journal.pone.0095091.g001
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Considering that results of DHR under the stress were
inconsistent with the other three parameters, we suspected that,
in contrast to the power spectral analysis on HR variation, DHR
itself did not seem a good parameter to measure the inter-strain
difference (Table 1); it might be too sensitive to various
environmental noises.
Although influence of physical activity on HR and BP could be
excluded in the restraint stress experiments (rats could not move at
all), it might influence HR and BP in the cold stress experiments.
In the present study, we could not monitor the physical activity of
rats because of a technical difficulty, however, we expected the
influence was small because a small size of cages used in the
experiments did not give rats enough space to move around. This
was further supported by the fact that the results of the restraint
and the cold stress experiments were consistent with each other.
Refinement of the Boundary of the Candidate Region
According to the physiological studies above, a gene (or genes)
responsible for the exaggerated sympathetic response in SHRSP
seemed to be in the region covered not by SPwch1.71 but by 1.72
(see Figure 1). To determine the boundaries of the target region,
the recombinant breakpoints of the congenic regions in
SPwch1.71 and in SPwch1.72 were refined. By genotyping of
single-nucleotide polymorphisms (SNPs) located between
D1Smu13 and D1Got154 (SNPs used in the genotyping are listed
in Table S2), we identified that the recombinant breakpoint of the
congenic fragment in SPwch1.72 at the telomeric side was located
between D1Wox33 and a SNP in the coding region of the Olr111
gene, and that of the fragment in SPwch1.71 was between SNPs in
the Trpc2 and in the Art5 gene, respectively (Figure 1 and Table
S2). As a result, we narrowed down the candidate region between
the SNP in Art5 and D1Wox33 as the minimal estimation (1.2-
Mbp) or between the SNPs in Trpc2 and in Olr111 as the maximal
estimation (1.8-Mbp) (Figure 1).
Evaluation of Candidate Genes
In 1.8-Mbp of the maximally estimated candidate region, we
identified 69 annotated genes, 2 predicted genes and 18
pseudogenes. Among the annotated genes, 59 were genes for
olfactory receptors. After excluding the pseudogenes and the genes
for olfactory receptors, 12 genes (10 were annotated) were located
in this region (Figure 1 and Table S3). We compared the
expression level of the 12 genes in the brainstem between WKY
and SHRSP. The expression of Trpc2, Art5, Art1, Chrna10 and
LOC685521 were minimal or absent, and thus were excluded from
the candidate genes (data not shown). Among the rest of 7
candidate genes, none showed a significant difference in the basal
expression between the two strains. Under the cold stress, on the
other hand, Nup98 and Pgap2 showed a modest, but statistically
significant, difference in the gene expression between SHRSP and
WKY (Figure 2).
The whole-genome sequence analysis of WKY/Izm and
SHRSP/Izm identified nonsynonymous single-nucleotide substi-
tutions in three genes, Art1, Stim1 and Trim21, of the 12 candidate
genes (Table 2). Art1 was, however, excluded because the
expression was not detectable in the brainstem (see above). In
Trim21, we identified two nonsynonymous nucleotide substitutions
(Table 2). One of them, the A to G substitution at 160,175,885 bp
(p.Ile474Met) was found in WKY/Izm while SHRSP/Izm had the
wild-type allele. As the two strains did not share the same allele,
this missense substitution might cause phenotypic differences
between SHRSP and WKY.
Eventually, four genes, Stim1, Nup98, Pgap2 and Trim21,
remained putative candidate genes. Among them, Stim1 was the
most promising candidate because of the functional role (see
Discussion) and of a nonsense mutation found in the 39-end of the
coding region in SHRSP (Table 2). As expected from the sequence
analysis, a western blot analysis revealed that a truncated form of
STIM1 was expressed in the brainstem of SHRSP (Figure 3A). In
addition, the level of the STIM1 protein was significantly lower in
SHRSP than in WKY regardless of whether exposed to cold stress
or not (Figure 3A and 3B).
Genotyping of the two variations in Stim1 was performed in
seventeen rat strains including 3 substrains of WKY, 4 of SHR and
4 of SHRSP, which showed that the stop codon responsible for the
truncation was identified only in 4 substrains of SHRSP (except
SHRSPA1-sb) and 1 substrain of SHR, i.e., SHR/Kyushu
(Table 3). Neither WKYs nor other major laboratory rat strains
shared this nonsense mutation (Table 3).
We found another nonsynonymous substitution (p.Leu488Phe)
in STIM1 that was specific for WKY/Izm and WKY/NCrj,
which may have functional significance as well (Table 2 and
Table 3).
Table 1. Evaluation of stress response in the congenic strains.
Strain
Parameters SHRSP SPwch1.71 SPwch1.72 WKY
BP (mmHg) 213631 (4) 209619 (4) 212624 (4) 111610*(6)
DBP (mmHg), Restraint 22.4611.8 (4) 33.868.1 (4) 2.063.3*(4) 4.165.7*(6)
Cold 34.464.3 (4) 48.1617.7 (4) 15.766.1*(4) 17.368.1*(6)
HR (bpm) 331671 (3) 272621 (4) 348640 (4) 343618 (6)
DHR (bpm), Restraint 67.2618.4 (3) 100.1620.9 (4) 102.1610.9*(4) 33.3620.3*(6)
Cold 179.0632.6 (3) 189.2627.0 (4) 96.9660.0 (4) 127.1620.0*(6)
DLF/HF, Restraint 3.3860.51 (5) 3.3561.00 (5) 1.9261.11*(5) 0.3460.30*(5)
DNE (mmol), Cold 0.57260.096 (10) 0.59660.061 (10) 0.34160.046*(10) 0.17360.069*(16)
Baseline blood pressure (BP), heart rate (HR), increase in BP (DBP), HR (DHR), LF/HF (DLF/HF, a parameter for the relative sympathetic activity), and changes in urinary
norepinephrine excretion (DNE) under cold and restraint stress in SHRSP were compared with those in SPwch1.71,SPwch1.72 and WKY [5]. The numbers of rats used for
each analysis are shown in parentheses. *P,0.05 vs. SHRSP by Dunnett’s post-hoc test.
doi:10.1371/journal.pone.0095091.t001
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Discussion
The previous study indicated that the congenic region covered
by SPwch1.72 harbored a gene (or genes) responsible for the
exaggerated stress response in SHRSP [5]. In the present study,
we further narrowed down the region to a 1.2-Mbp fragment, and
identified a new candidate, Stim1, among the genes located in this
region.
In the region covered by SPwch1.72, we initially found a strong
functional candidate gene, Phox2a, a transcription factor regulating
the expression of Th as well as the development of SNS in utero
[6,7]. We therefore attempted to make another congenic strain
(SPwch1.71) covering a small fragment including Phox2a (Figure 1).
The physiological evaluation of this congenic strain indicated that
the region harboring Phox2a could be excluded from the region
responsible for the difference in the stress response between
SHRSP and WKY (Table 1 and Figure 1). The refinement of the
congenic boundaries using newly identified SNPs in this region
excluded Ship2 from the candidate genes as well (Figure 1).
Although the two candidate genes were excluded, we identified
another candidate gene, Stim1, in the newly defined target region,
which harbored a nonsense mutation (p.Arg640X) in SHRSP
(Table 2). STIM1 is a Ca2+-storage sensor protein localized on the
endoplasmic reticulum (ER) and plasma membrane, and is an
essential component in the store-operated calcium entry (SOCE)
process through regulating a calcium channel, ORAI1, on the cell
membrane [17–21]. The SOCE was found in various types of
cells, including neurons, and shown to play important roles in
a variety of cellular functions [22,23]. The nonsense mutation
found in SHRSP resulted in a truncation of 46 amino acids at the
C-terminal end of the rat STIM1 that was indeed shown by the
western blot analysis with anti-STIM1 (N-terminal) polyclonal
antibody (Figure 3A). The specificity of the analysis was confirmed
with another anti-STIM1 monoclonal antibody (Abnova, clone
5A2, data not shown).
Of note, it is suggested that the C-terminus lysine residues
(K684, K685), which were lost in the truncated form, were
essential in interaction of STIM1 with the transient receptor
potential cation channel 1 (TRPC1), another type of cation
channels on the cell membrane [24]. As STIM1 was postulated to
control the gating of TRPC1, it is attractive to hypothesize that the
truncation in STIM1 is causally related to the exaggerated
response of SNS in SHRSP through abnormal regulation of
TRPC1. In addition, Bauer et al. showed that calmodulin bound
to the polybasic C-terminal of STIM1 in a calcium-dependent
manner [25]. This implied that the lack of the C-terminal residues
of STIM1 affected the calmodulin-dependent regulation of
STIM1 as well.
In addition to the truncation, we also found the protein level of
STIM1 in the brainstem was lower in SHRSP when compared
Figure 2. Expression analysis of candidate genes in the brainstem of WKY and SHRSP. Five rats of the each strain were used. Ventrolateral
part of the brainstem including RVLM was dissected and RNA was extracted. Relative levels of gene expression were evaluated by quantitative RT-PCR
analysis. The expression levels of each gene were normalized with b-actin mRNA. Each column shows the expression level of WKY and SHRSP under
the room temperature (RT) or under the cold stress (Cold) as indicated in the panel for Nup98. SP: SHRSP, *P,0.05 vs. WKY under the cold stress by
Student’s t-test.
doi:10.1371/journal.pone.0095091.g002
Table 2. Nonsynonymous substitutions identified in candidate genes located in a 1.8-Mbp region on chromosome 1.
Genomic position Nucleotide and amino acid
(bp)* Gene Reference WKY/Izm SHR/Izm SHRSP/Izm
15,95,90,430 Art1 C (Arg) C (Arg) T (STOP) T (STOP)
15,99,15,391 Stim1 G (Leu) C (Phe) G (Leu) G (Leu)
15,99,24,291 Stim1 C (Arg) C (Arg) C (Arg) T (STOP)
16,01,75,885 Trim21 A (Ile) G (Met) A (Ile) A (Ile)
16,01,76,069 Trim21 A (Gln) A (Gln) T (Leu) A (Gln)
*The genomic position of SNP is defined based on the RGSC Genome Assembly v3.4.
doi:10.1371/journal.pone.0095091.t002
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with WKY although the mRNA expression level was not
significantly different (see Figure 2 and Figure 3). Keil et al. raised
a possibility that the ubiquitin-proteasome system regulated the
STIM1 protein level when the SOCE was activated [26]. The
truncated STIM1 might be degraded more rapidly in this system,
which might resulted in the decreased level of STIM1 in SHRSP.
The difference in the protein level per se may have a functional
significance even if the truncation is pathologically innocent.
In this context, it is of note that Giachini et al. showed that
augmented activity of STIM1 and ORAI1 in the aorta of SHRSP
resulted in greater SOCE-dependent vasoconstriction [27]. They
found that the protein expression of both STIM1 and ORAI1 was
increased in the aorta of SHRSP when compared with WKY.
Further, they revealed that the SOCE inhibitors (2-aminoethox-
ydiphenyl borate and gadolinium) as well as neutralizing
antibodies against STIM1 and ORAI1 abrogated the SOCE-
dependent vasoconstriction observed in SHRSP. Their findings
indicated that augmented activity of STIM1 and ORAI1 might be
causally related to hypertensive phenotype in SHRSP. As far as
our results of western blotting are concerned, however, the present
results are inconsistent with those in the report by Giachini et al.
in terms of the molecular size and the expression level of STIM1 in
SHRSP (see Figure 3). Although we do not have a good
interpretation on this discrepancy, the different source of SHRSP
used in the experiments might affect the results. In fact, we found
that the allele of Stim1 in SHRSPA1-sb (a substrain of SHRSP)
differed from that in SHRSP/Izm (Table 3). In addition, different
tissue used in the experiments (i.e., the brainstem vs. the aorta)
might explain the discrepancy in the expression level of STIM1
between the two reports.
In anyway, difference in the STIM1 protein expression, which
was a rather unexpected result, must be confirmed between
SPwch1.71 and 1.72 to obtain more robust evidence on influence
of the Stim1 genotype on the protein expression.
The fact that the substrains of SHRSP shared the nonsense
mutation in Stim1 implicated an important role of this gene in
Figure 3. Western blot analysis of STIM1. A) Western blotting was
performed as described in the Materials and Methods. The size of STIM1
in SHRSP was obviously smaller than that in WKY. A representative data
is shown. B) Semi-quantitative evaluation of the STIM1 protein level was
performed using ImageJ software. The relative amount of STIM1 was
standardized with the level of b-actin. Room temp: room temperature,
*P,0.05 vs. WKY by Student’s t-test.
doi:10.1371/journal.pone.0095091.g003
Table 3. Allelic difference of the two sequence variations identified in Stim1 in various rat strains.
Position and nucleotide
Strains 159,915,391 bp 159,924,291 bp
WKY/Izm C C
W/Kyo G C
WKYO/Kyo G C
WKY/Crj C C
SHR/Izm G C
SHR/B2 G C
SHR/CL G C
SHR/Crj G C
SHR/Kyushu G T
SHRSP/Izm G T
SHRSPA1-sb G C
SHRSPA4 G T
SHRSP/Ngsk G T
SHRSP/Ezo G T
SDJ/Hok G C
LEJ/Hok G C
F344/NSlc G C
LEW/SsNSlc G C
SS/JrNgS G C
SR/JrNgS G C
Genomic position of each SNP is defined based on RGSC Genome Assembly v3.4.
doi:10.1371/journal.pone.0095091.t003
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generation of SHRSP-specific phenotype. However, we had two
exceptions, i.e., SHR/Kyushu and SHRSPA1-sb; SHR/Kyushu,
a substrain of SHR, shared the same allele with SHRSP/Izm,
while SHRSPA1-sb did not (Table 3). According to the original
study describing the establishment of SHRSP, SHRSPA1-sb was
developed in parallel with SHRSPA3 (which is now called
SHRSP/Izm), and showed lower BP than that in SHRSPA3
[28]. In addition, SHR/Kyushu was a descendant of the
‘‘original’’ SHR that was not yet separated from SHRSP, and
therefore was expected to share some phenotypic and genotypic
features with SHRSP. In fact, Cai et al. showed that SHR/
Kyushu was more vulnerable to the middle cerebral artery
occlusion to give larger infarction areas when compared with
SHR/Izm [29].
In this context, evaluation of the sympathetic stress response
between SHR/Izm and SHR/Kyushu may provide further
evidence on the influence of the truncated STIM1 on the
sympathetic stress response. We therefore compared urinary NE
excretion under the cold stress between the two SHR substrains
(Figure S1). The excretion in SHR/Kyushu (with the SHRSP
allele of Stim1) tended to be greater when compared with SHR/
Izm (with the wild-type allele of Stim1), though the difference did
not reach a significant level (P=0.088). As SHR/Kyushu shared
the same genetic background with SHRSP in substantial areas of
Chr1, other genes in the background might modify the result [12].
The influence of the genetic background other than Stim1 on the
urinary NE excretion was further supported by the fact that
SPwch1.72, which shared the same allele of Stim1 with WKY,
showed significantly greater NE excretion than that in WKY (P,
0.001, see Table 1).
Another missense variation specific for WKY/Izm and WKY/
NCrj may have functional importance (Table 3); Mullins et al.
reported that a short domain of STIM1 (residues 470–491) was
required for Ca2+-dependent inactivation of ORAI1 [30]. This
finding implies that the p.Leu488Phe mutation identified in the
two substrains of WKY may influence the SOCE activity via
interaction with ORAI1.
Nup98 and Pgap2 were potential candidate genes because the
significant differences in the gene expression under the cold stress
were observed between SHRSP and WKY (Figure 2). To our
knowledge, promoter sequences or transcription factors regulating
the expression of Nup98 and Pgap2 remains to be determined.
Based on the sequence analysis of SHRSP and WKY, we found
three sequence variations in the 59-untraslational region of the two
genes; a G to T substitution at 1,836 bp upstream from the first
exon of Nup98, and a C to T and a T to C substitution at 1,729 bp
and 4,390 bp upstream from the first exon of Pgap2, respectively.
We thus searched for possible transcription factors bound to the
genomic sequences including the three substitutions above using
the TRANSFAC MATCH v.1.0. The results indicated that no
such transcription factors were so far identified, and the functional
significance of the three substitutions was unclear.
Further, as far as the gene functions currently annotated are
considered, these two genes do not seem strong candidates for the
genes regulating sympathetic nervous activity; Pgap2 encodes
a Goldi/ER-resident membrane protein and is involved in fatty
acid glycosylphosphatidylinositol (GPI)-anchor remodeling, which
is required for stable association of GPI-anchored proteins and the
cell-surface membrane rafts [31,32]. NUP98 is a member of
nucleoporins and the formation of fusion genes with various
partner genes was reported to be associated with hematopoietic
malignancy [33]. In spite of the discussion above, to obtain further
clues for the candidacy, the expression of these genes in
SPwch1.71 and 1.72 needs to be examined in a future study. In
addition, although differences in the expression of Nup98 and
Pgap2 between WKY and SHRSP were statistically significant, the
difference was rather modest (1.2 and 1.3 fold, respectively, see
Figure 2) and requires confirmation at the protein level.
Trim21 remained to be a putative candidate gene because of the
A to G nonsynonymous substitution (p.Ile474Met) was identified
between WKY and SHRSP (Table 2). TRIM21, also known as
Ro52, has the E3 ligase activity involved in the ubiquitination
process and it was reported that autoantibodies against this protein
were detected in patients with several autoimmune diseases, e.g.,
primary Sjo¨gren’s syndrome [34]. As in the case of NUP98 and
PGAP2, the function of TRIM21 currently annotated does not
strongly infer roles of this gene in the sympathetic stress response.
Based on the discussion above, at the moment, we concluded
that Stim1 was the most promising among the four putative
candidates. In spite of that, careful further evaluation of the other
three genes is essential before they are excluded from candidate
genes for sympathetic stress response.
In conclusion, we found that Stim1 is the best candidate in terms
of the gene function as well as of the potential significance of the
sequence variations identified in it. Accumulating evidence
suggests that STIM1 is involved in various pathophysiological
processes such as inflammatory immune response, cardiac
hypertrophy and hypertension [27,35,36]. In spite of that, roles
of STIM1 and TRPCs in normal and in pathological conditions
are not fully elucidated. To obtain conclusive evidence for the
causative role of the truncated STIM1, it is essential to clarify
effects of the truncation (or the low expression) on the cellular
calcium dynamics. Further studies on the role of STIM1 in the
regulation of SNS are warranted.
Supporting Information
Figure S1 Evaluation of sympathetic response to cold
stress in SHR/Izm and SHR/Kyushu. A rat was place in
a metabolic cage kept at 4uC for 6 hours. An urine sample was
collected for HPLC analysis of urinary norepinephrine excretion
(NE) and changes in urinary NE (DNE) under cold stress was
evaluated. Nine rats of the each strain were used for the
experiment. P value was calculated by Student’s t-test and shown
at the top of columns.
(PPTX)
Table S1 Primer sequences for quantitative RT-PCR
analysis.
(PPTX)
Table S2 Primer sequences for SNP-based genotyping.
UTR; untranslated region, CDR; coding region. *The genomic
position of each SNP is defined based on the RGSC Genome
Assembly v3.4.
(PPTX)
Table S3 Putative genes in the 1.8-Mbp congenic
fragment.
(PPTX)
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